Trial Profile
Clinical study on the effects of vildagliptin on glucose and lipid profiles in patients type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Oct 2017
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- 12 Oct 2017 Status changed from active, no longer recruiting to completed.
- 17 Apr 2013 New trial record